Vol 12, No 3 (2016)

May/June

Open Access Open Access  Restricted Access Subscription or Fee Access

Table of Contents

Articles

Abuse deterrence testing: A dose ratio escalation study examining naloxone coadministered with intravenous hydromorphone in non-treatment-seeking, opioid-dependent drug users
Naama Levy-Cooperman, PhD, Kerri A. Schoedel, PhD, Joseph L. Reiz, BSc, David Thompson, PhD, Bijan Chakaraborty, MStat, Pierre Geoffroy, MD, Kenneth J. Michalko, PharmD, MBA
PDF
165-180
Effect of preoperative intravenous oxycodone on sufentanil consumption after laparoscopic radical gastrectomy
Jinguo Wang, MD, PhD, Yaowen Fu, MD, PhD, Honglan Zhou, MD, PhD, Na Wang, MD, PhD
PDF
181-185
Effectiveness and tolerability of tapentadol sustained release in the Australian setting
Marc A. Russo, MBBS, DA(UK), FANZCA, FFPMANZCA, Danielle M. Santarelli, PhD
PDF
187-196
Fentanyl in a pectin gel treating breakthrough pain
Borja Mugabure Bujedo, MD, Brynjar Karlsson, PhD
PDF
197-203
Acceptability of the use of cellular telephone and computer pictures/video for “pill counts” in buprenorphine maintenance treatment
Christopher Welsh, MD
PDF
217-220

Review Articles

Risk factors for opioid misuse in adolescents and young adults with focus on oncology setting
Kelly R. Peck, MA, Jennifer Harman Ehrentraut, PhD, Doralina L. Anghelescu, MD
PDF
205-216

ICOO Conference Information

International Conference on Opioids, June 5-7, 2016
 
PDF
221-228